First announced in August 2022, the 30,000-square metre facility will have the world’s highest production of sensors used in ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

Carbon pricing is about recognizing the cost of pollution and accounting for those costs in our daily decisions by choosing less carbon-intensive options. Fuel charge: paid by fuel distributors and ...

Insulet’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on the significant growth opportunities in the Type 2 diabetes space. PODD ...

Abbott's FreeStyle Libre 2 and 3 continuous glucose monitors no longer need to be removed for imaging tests. CGM readings during an MRI may be affected for up to an hour after the procedure. While ...

iLet Bionic Pancreas The iLet Bionic Pancreas With the FreeStyle Libre 3 Plus Sensor Beta Bionics' flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower growth expectations. Revenue guidance was cut from $4.2-$4.35 billion ...

The Williams Racing FW46 driven by Alex Albon and Franco Colapinto in Mexico and Brazil will feature partner Mercado Libre’s statement yellow branding on the engine cover – in a nod to the team’s ...

Notably, sales of the FreeStyle Libre, the popular glucose scanning device has contributed $1.6 billion in the overall revenue figure, and bringing in a jump of 21% during the quarter. In fact ...